NWG:LSE
NatWest Group Plc
Data as of 2026-03-10 - not real-time
£575.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
NatWest Group trades at 575.8 GBp, hugging a near‑term support level of 556 GBp while the 20‑day SMA (603.6) sits just above price, suggesting limited upside in the immediate window. The RSI of 36.9 points to modest oversold conditions, yet the MACD remains bearish and the 30‑day volatility is high at ~40%, implying price swings could test the support before any breakout. Volume trends are decreasing, but short interest is negligible (0.02% of float), meaning a short‑cover rally is unlikely to drive the stock higher in the short run.
Fundamentally, the bank appears undervalued with a trailing P/E of 8.6 versus an industry average of 17.4 and an upside potential of roughly 24% based on analyst targets. Revenue grew 11.4% YoY, EPS surged 27%, and the dividend yield stands at a robust 5.65% with a comfortable payout ratio of 37%, supported by a strong cash position that exceeds total debt. Analyst sentiment is positive, highlighted by UBS naming NatWest a top pick in European banking and a recent lift in fair‑value estimates.
Fundamentally, the bank appears undervalued with a trailing P/E of 8.6 versus an industry average of 17.4 and an upside potential of roughly 24% based on analyst targets. Revenue grew 11.4% YoY, EPS surged 27%, and the dividend yield stands at a robust 5.65% with a comfortable payout ratio of 37%, supported by a strong cash position that exceeds total debt. Analyst sentiment is positive, highlighted by UBS naming NatWest a top pick in European banking and a recent lift in fair‑value estimates.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Price near technical support with bearish MACD
- High short‑term volatility and decreasing volume
- Low short interest reducing upside catalyst
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Attractive valuation multiples versus peers
- Strong earnings and revenue growth momentum
- High dividend yield with sustainable payout
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- Robust capital position (cash > debt)
- Consistent dividend policy supporting shareholder returns
- Long‑run earnings upside reflected in analyst price targets
Key Metrics & Analysis
Financial Health
Revenue Growth11.40%
Profit Margin36.51%
P/E Ratio8.6
ROE14.23%
ROA0.82%
P/B Ratio121.1
Op. Cash Flow£-12416000000
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI36.9
Support£556.00
Resistance£634.20
MA 20£603.60
MA 50£633.14
MA 200£569.07
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Target Price£718.38
Upside/Downside24.76%
GradeUndervalued
TypeBlend
Dividend Yield5.65%
Risk Assessment
Beta0.53
Volatility39.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.